Testing Meldonium: Assessing Soviet pragmatic alternatives to the randomized controlled trial

Area of Science:

• Pharmacopolitics and Drug Development
• History of Medicine and Soviet Science
• Clinical Trial Methodologies

Background:

• Current research often overlooks the drug-testing models developed in the "Second World" as alternatives to randomized controlled trials (RCTs).
• The Soviet Union's influence shaped a distinct "socialist pharmapolitics" approach to experimental drug development and testing.
• This study examines the Soviet clinical trials model, heavily influenced by the USSR during the Cold War.

Purpose of the Study:

• To present an empirical case study of a late Soviet clinical trial as a pragmatic alternative to the RCT model.
• To account for the divergences between the officially prescribed Soviet model and the actual practices in healthcare.
• To outline the factors that shaped the organization of clinical trials within Soviet institutions.

Main Methods:

• Conducted archival research at the Russian State Archive of Scientific and Technical Documentation.
• Analyzed scientific, technical, and registration documentation for the experimental drug Meldonium, including trial reports.
• Employed manual content analysis for the interpretation of archival data.

Main Results:

• The Soviet drug testing model exhibited significant differences from Western RCTs, both officially and in practice.
• Late Soviet clinical trials, specifically for Meldonium, incorporated elements of randomization, double-blinding, and placebo use.
• These practices contrasted with the formal denouncement of such methods by Soviet bioethics guidelines.

Conclusions:

• The Soviet model for experimental drug testing substantially differed from Western approaches.
• Enforcement in practice led to significant deviations from officially proclaimed Soviet methodologies.
• Important discrepancies existed between the official Soviet drug trial model and the realities of clinical practice.